IceCure Medical (ICCM) Research & Development (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Research & Development data on file, last reported at $2.2 million in Q1 2026.

• Research & Development for Q1 2026 came in at $2.2 million, up 32.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.0 million (up 17.2% YoY), and the FY2025 annual result was $7.4 million, up 4.75% from the prior year.
• Research & Development eased to $2.2 million in Q1 2026 per ICCM's latest filing, from $2.3 million in the prior quarter.
• Over five years, Research & Development peaked at $2.4 million in Q1 2022 and troughed at $1.6 million in Q2 2024.
• A 5-year average of $2.0 million and a median of $2.1 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2024: Research & Development surged 109.27% in 2022, then slipped 23.76% in 2024.
• A 5-year view of Research & Development shows it stood at $2.2 million in 2022, then declined by 15.82% to $1.9 million in 2023, then declined by 9.98% to $1.7 million in 2024, then surged by 35.46% to $2.3 million in 2025, then fell by 3.7% to $2.2 million in 2026.
• Business Quant data shows ICCM's Research & Development at $2.2 million in Q1 2026, $2.3 million in Q4 2025, and $1.8 million in Q3 2025.